SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-21-015081
Filing Date
2021-04-30
Accepted
2021-04-30 09:13:24
Documents
6
Period of Report
2021-06-11

Document Format Files

Seq Description Document Type Size
1 DEF 14A nc10022093x1_def14a.htm DEF 14A 679622
2 logo_kinnatebiopharma.jpg GRAPHIC 36621
3 nc10022093x1_proxy01.jpg GRAPHIC 553788
4 nc10022093x1_proxy02.jpg GRAPHIC 438313
5 sig_deanmitchell.jpg GRAPHIC 13796
6 sig_nimafarzan.jpg GRAPHIC 12037
  Complete submission text file 0001140361-21-015081.txt   2131801
Mailing Address 11975 EL CAMINO REAL, STE 101 SAN DIEGO CA 92130
Business Address 11975 EL CAMINO REAL, STE 101 SAN DIEGO CA 92130 8582994699
Kinnate Biopharma Inc. (Filer) CIK: 0001797768 (see all company filings)

IRS No.: 824566526 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39743 | Film No.: 21874153
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences